Predictions
Sernova Corp.
Start price
Target price
Perf. (%)
€0.65
05.01.23
05.01.23
€25.00
05.02.23
05.02.23
23.66%
06.02.23
06.02.23
Could be very worthwhile Investment >20% year
Canopy Growth Corp
Start price
Target price
Perf. (%)
€2.42
22.01.23
22.01.23
-
22.01.24
22.01.24
12.21%
05.02.23
05.02.23
Could be very worthwhile Investment >20% year
Organigram Holdings Inc.
Start price
Target price
Perf. (%)
€4.86
28.01.22
28.01.22
€7.20
28.01.23
28.01.23
-32.31%
29.01.23
29.01.23
Aphria Inc.
Start price
Target price
Perf. (%)
€12.71
21.01.23
21.01.23
-
24.05.24
24.05.24
-
26.01.23
26.01.23
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Canopy Growth Corp
Start price
Target price
Perf. (%)
€1.86
23.04.16
23.04.16
€18.58
22.10.24
22.10.24
40.44%
24.01.23
24.01.23
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€4.58
17.11.22
17.11.22
-
17.11.23
17.11.23
-14.78%
26.12.22
26.12.22
Canopy Growth Corp
Start price
Target price
Perf. (%)
€2.80
10.12.22
10.12.22
-
10.12.23
10.12.23
-21.61%
24.12.22
24.12.22
Risky Investment
Canopy Growth Corp
Start price
Target price
Perf. (%)
€2.44
17.10.22
17.10.22
-
17.10.23
17.10.23
-7.41%
22.12.22
22.12.22
Risky Investment
Aptose Biosciences
Start price
Target price
Perf. (%)
€0.98
14.12.21
14.12.21
-
14.12.22
14.12.22
-39.08%
15.12.22
15.12.22
Could be worthwhile Investment >10% per year
Canopy Growth Corp
Start price
Target price
Perf. (%)
€8.47
13.12.21
13.12.21
-
13.12.22
13.12.22
-67.06%
14.12.22
14.12.22
Could be very worthwhile Investment >20% year
Revenue decline/stagnation expected
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€4.85
01.12.21
01.12.21
-
01.12.22
01.12.22
-53.67%
02.12.22
02.12.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Stable Large shareholder and/or long term investor
Future proof or reliable business model
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.05
20.09.22
20.09.22
€1.80
20.09.23
20.09.23
36.59%
19.11.22
19.11.22
Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Canopy Growth Corp
Start price
Target price
Perf. (%)
€2.55
13.10.22
13.10.22
€2.30
13.10.23
13.10.23
42.55%
19.11.22
19.11.22
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Risky balance sheet
Canopy Growth Corp
Start price
Target price
Perf. (%)
€13.55
13.11.21
13.11.21
-
13.11.22
13.11.22
-69.88%
14.11.22
14.11.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Innovative
Future proof or reliable business model
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.59
03.11.22
03.11.22
-
03.11.23
03.11.23
-6.74%
12.11.22
12.11.22
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€5.35
03.11.22
03.11.22
-
03.11.23
03.11.23
-5.40%
12.11.22
12.11.22
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€7.12
23.10.22
23.10.22
-
23.10.23
23.10.23
-24.89%
03.11.22
03.11.22
Canopy Growth Corp
Start price
Target price
Perf. (%)
€6.44
28.01.22
28.01.22
-
28.01.23
28.01.23
-63.05%
25.10.22
25.10.22
Could be worthwhile Investment >10% per year